Analytics & PAT

Walk-away microplate processors that automate the full ELISA workflow — sample and reagent dispensing, incubation, washing and photometric reading — for clinical diagnostics, blood-donor screening and biopharma potency/immunogenicity testing, replacing manual multi-step plate handling with a closed, standardized instrument run.

In-line sensing, chromatography and mass spectrometry that turn biomanufacturing into data-driven, feedback-controlled production — a stack from probe to real-time release.

Capillary-based separation instruments — CE-SDS purity assays, imaged capillary isoelectric focusing (icIEF) for charge-variant analysis, CE-mass spectrometry, and microfluidic chip electrophoresis for nucleic-acid fragment sizing — that replace slab-gel electrophoresis with automated, higher-resolution biopharma characterization and QC.

Bench-top instruments that automate cell counting and viability assessment — image-based dye-exclusion counters, fluorescence-based analyzers and closed-cassette systems — replacing manual hemocytometer counting for daily cell-culture QC, bioreactor process monitoring and cell-therapy/cell-line release testing.

Cartridge-based readers, kinetic microplate assays and reagent systems that detect bacterial endotoxin in injectable drugs, biologics and medical devices — the mandatory release test standing between every parenteral batch and market, now mid-transition from horseshoe-crab-derived LAL reagent to animal-free recombinant cascade reagents.

Bench-top and process-scale instruments that measure and sort individual cells by fluorescence and light scatter — spectral analyzers, high-speed sorters and acoustic-focusing cytometers — the standard tool for CAR-T/cell-therapy release, immunophenotyping and cell-line development across bioproduction.

Bench-top liquid chromatography systems — HPLC and ultra-high-performance UPLC platforms — that separate and quantify proteins, peptides, small molecules and impurities ahead of UV, fluorescence or mass-spectrometry detection, the workhorse instrument for biopharma purity testing, release assays and formulation characterization.

High-resolution and tandem mass spectrometers — Orbitrap, time-of-flight and triple-quadrupole platforms — that characterize protein identity, post-translational modifications, impurities and peptide biomarkers, from deep proteomics research through GxP biopharma release and clinical/forensic quantitation.

Bench-top instruments that size and charge-characterize particles from nanometers to millimeters — dynamic light scattering, laser diffraction, nanoparticle tracking and multi-angle light scattering — the standard release and formulation-R&D toolkit for lipid nanoparticles, biologics aggregates, extracellular vesicles and industrial powders.

Multimode microplate readers that measure absorbance, fluorescence, luminescence and time-resolved FRET across 96-, 384- and 1536-well plates — the shared detection backbone behind ELISA, cell viability, reporter-gene and high-throughput screening assays across biopharma R&D and QC.

Industrial automation software orchestrating complex bioreactor operations and enforcing regulatory compliance through electronic batch records.

Membrane-filtration pump systems, automated colony-detection platforms and rapid microbial detection instruments that confirm a parenteral product is free of viable microorganisms before release — a mandatory 14-day compendial test now increasingly compressed to hours or days by validated rapid alternative methods.